(PharmaNewsWire.Com, December 09, 2017 ) According to the report Middle-East & Africa Anti-venom Market, published by Market Data Forecast, the Middle-East and Africa market is projected to reach USD 124.2 million by 2021, at a CAGR of 6.67% from 2016 to 2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 15,000-20,000 people die with snake bites annually in Europe.
To overcome poisonous effects after venomous bites the manufacturers developed number of Antivenom products including vaccines and hyperimmune sera. This has been due to a combination of factors, including Inadequate investment by governments and non-government organisations, High manufacturing costs and inefficient production processes, Inconsistent quality standards; and Inappropriate clinical application.
Middle-East & Africa Antivenom Market: Drivers & Restraints Growing number of venomous animals bite cases, rising demand for antivenom products, emergence of new Pan-African polyvalent antivenom products using modern proteomic & antivenomic tools, and presence of antivenom financing systems are driving the growth of the Middle-East & Africa Antivenom Market. However, dearth of antivenom products, high manufacturing costs of antivenom products, decreasing antivenom production, and limited adoption of antivenom products are hampering the growth of Middle-East & Africa Antivenom Market.
Middle-East & Africa Antivenom Market: Segmentation
By Type Introduction Vaccines Hyperimmune Sera o Homologous o Heterologous Y-o-Y Growth Analysis, By type Market Attractiveness Analysis, By Type Market Share Analysis, By Type
By Animal Introduction Snakes Scorpions Spiders Others Y-o-Y Growth Analysis, By Animal Market Attractiveness Analysis, By Animal Market Share Analysis, By Animal
Middle-East & Africa Antivenom Market: Overview As discussed earlier, Snake bite is a neglected public health issue in many tropical and subtropical countries. About 5 million snake bites occur each year, resulting in up to 2.5 million envenomings (poisoning from snake bites), at least 100 000 deaths and around three times as many amputations and other permanent disabilities. Recent studies of pharmacokinetics of envenoming permitted improved understanding of immunotherapy. Improved purification of the antivenom by using immunoglobulin fragments has led to increased tolerance and efficiency of antivenoms. The immunisation procedures and purification and use of IgG fragments for use in antivenoms development can be improved further using modern technology.
Middle-East & Africa Antivenom Market: Region-wise Outlook On the basis of geographical areas, Middle East & Africa Antivenom market is segmented as Middle East, South Africa, and rest of Middle East & Africa. The Middle East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include UAE, Saudi Arabia, South Africa and Qatar.
Key Questions Answered What is the current and future Antivenom market outlook in Middle-East & Africa? What trends are affecting the Middle-East & Africa market? What is the competitive landscape and market share of major players in the Antivenom space in Middle-East & Africa? What are the key, high growth markets that Antivenom manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Antivenom currently on the market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Antivenom? What are the challenges and barriers that have hindered widespread adoption of Antivenom? Middle-East & Africa Antivenom Market: Key Players
Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
Reasons to buy Middle-East & Africa Antivenom Market Report: Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Biotechnology Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
